Silicon Valley has audacious plans for shaking up the way we diagnose — and cure — disease.
But the life sciences are far more challenging than the tech titans of this world might realize: There are countless regulatory hurdles, health care delivery obstacles, and — most of all — the challenge of untangling the extraordinarily complex biology of the human body.
About the Author Reprints
